Researchers at Mayo Clinic have designed an artificial intelligence model that can potentially predict an individual’s risk of developing pancreatic cancer years before diagnosis. Research will be presented at the…
cancer
-
-
Startup
London-based Big Picture Bio emerges from stealth with €2.55 million to develop AI-designed cancer drug combinations
Big Picture Bio, a London-based BioTech startup developing AI-designed combination therapies for cancer and other complex diseases, has emerged from stealth with a combined funding round of €2.55 million (£2.2…
-
Md Babul Hosen/iStock via Getty Images The Food and Drug Administration approved Telix Pharmaceuticals’ (TLX) Pixclara, a radioactive imaging drug used to help evaluate patients with glioma, the company said…
-
Arizona has sued L’Oréal, accusing the cosmetics company of concealing evidence that its chemical hair relaxer products could increase the risk of cancer in women. Arizona Attorney General Kris Mayes…
-
Stocks
‘This has been an emotionally difficult time’: My brother has cancer and my father is 94. How do I shoulder this responsibility?
“My father placed his $600,000 Wisconsin home into a revocable trust, naming my brother as beneficiary.”
-
Stocks
‘It’s heartbreaking’: My brother claimed Social Security at 70. He died from cancer after one payment. Why wait to claim?
“I’ve always been a little skeptical of the government’s encouragement to delay claiming benefits.”
-
Investment
Stock Gains on News of 70% Surge in U.S. ProSense Install Base Fuels IceCure’s (NASDAQ: ICCM) Breast Cancer Treatment Momentum
IceCure’s FDA-cleared cryoablation system for breast cancer is gaining physician and patient traction, sending shares up more than 200% on heavy volume. Investorideas.com (www.investorideas.com) a go-to platform for big investing…
-
Stocks
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer…
-
Metastatic breast cancer (MBC) remains incurable, with approximately only one-third of diagnosed women meeting the five year survival rate. Subtypes like triple-negative breast cancer (TNBC) or heavily pretreated hormone receptor-positive…
-
An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a…
